CDC: 2 Million in U.S. Have Chlamydia
Rates Highest Among African-Americans, Teens
Screening for Chlamydia and Gonorrhea
CDC currently recommends annual chlamydia screenings for all sexually active
women under the age of 26, and annual screenings for older women with risk
factors for the STD, such as a new sex partner or multiple partners. Screening
is also recommended for all pregnant women.
Routine screening for gonorrhea is also recommended for women with a high
risk for infection, such as sex workers and women with new or multiple sex
The findings suggest that current chlamydia and gonorrhea screening
recommendations are adequate, assuming they are implemented, Datta says.
"If screening recommendations are properly applied they will be
effective, but we know that this isn't happening consistently," she says.
"This needs to be a focus of STD prevention."
The prevalence analysis appears in Tuesday's issue of the Annals of
Penicillin-Resistant Gonorrhea Down
In a separate study, published in the same issue of the journal, another
group of CDC researchers reported that the prevalence of penicillin-resistant
gonorrhea appears to be declining, while resistance to antibiotics in the class
known as fluoroquinolones is on the rise.
In April of this year the CDC recommended that fluoroquinolones no longer be
used to treat the infection because of rising resistance among both
heterosexual and gay men.
Now only one class of antibiotics -- cephalosporins -- is recommended for
the treatment of gonorrhea.
In a press release, CDC officials noted that the declining treatment options
underscored the need for new drugs to treat the infection and for better ways
to monitor drug resistance.
- Do you have questions about STDs? Discuss them with others on WebMD’s STDs: Member to Member